SELDI-TOF MS

A Proteomics Panel for Predicting Optimal Primary Cytoreduction in Stage III/IV Ovarian Cancer
Signe Risum, Estrid Høgdall, Svend A. Engelholm, Eric Fung, Lee Lomas, Christine Yip, Anette L. Petri, Lotte Nedergaard, Lene Lundvall, Claus Høgdall

International Journal of Gynecologic Cancer Nov 2009, 19 (9) 1535-1538; DOI: 10.1111/IGC.0b013e3181a840f5
Serum proteomic patterns for ovarian cancer monitoring
J. Helleman, D. Van Der Vlies, M. P.H.M. Jansen, T. M. Luider, M. E.L. Van Der Burg, G. Stoter, E. M.J.J. Berns

International Journal of Gynecologic Cancer Aug 2008, 18 (5) 985-995; DOI: 10.1111/j.1525-1438.2007.01139.x
Identifying Serum Biomarkers for Ovarian Cancer by Screening With Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry and the Artificial Neural Network
Jing Yang, Yanhui Zhu, Hongyan Guo, Xiuyun Wang, Ronglian Gao, Lufang Zhang, Yangyu Zhao, Xiaowei Zhang

International Journal of Gynecologic Cancer May 2013, 23 (4) 667-672; DOI: 10.1097/IGC.0b013e31827e1989

Main menu